Fund Holdings — BML Capital Management, LLC

Total Portfolio Value
$175.10M
Total Bought
$26.81M
Total Sold
$27.51M
Net Transaction
-$698.8K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ENGENE THERAPEUTICS INC(ENGN)06,669,908+6,669,908011,5396.59%+11,539
ACLARIS THERAPEUTICS INC(ACRS)14,250,00011,975,000-2,275,00053,43863,34836.18%+9,910
KRAFT HEINZ CO(KHC)125,000465,000+340,0002,81110,9836.27%+8,172
OUTSET MED INC(OM)1,902,2012,519,701+617,5007,30410,8856.22%+3,581
CARMAX INC(KMX)155,000172,500+17,5006,4459,1245.21%+2,679
PMV PHARMACEUTICALS INC(PMVP)5,320,0005,330,000+10,0006,5977,1424.08%+545
TARGET CORP(TGT)37,50037,50004,5454,8982.80%+353
TILLYS INC(TLYS)2,150,0002,150,00008,7089,0305.16%+323
CONNECT BIOPHARMA HLDGS LTD(CNTB)408,887573,287+164,4001,0711,3640.78%+293
JANUX THERAPEUTICS INC(JANX)154,961154,96102,1542,3801.36%+226
IMAGENEBIO INC(IMA)200,730200,73001,0041,1840.68%+181
PLIANT THERAPEUTICS INC(PLRX)1,546,1371,546,13701,9481,7631.01%-186
INSTIL BIO INC(TIL)645,600645,60005,3204,9652.84%-355
KEZAR LIFE SCIENCES INC
COM NEW
720,7870-720,7875,3480—-5,348
ATEA PHARMACEUTICALS INC(AVIR)7,058,6576,952,330-106,32737,97632,32818.46%-5,647
ORAMED PHARMACEUTICALS INC(ORMP)3,167,231866,269-2,300,96210,7694,1672.38%-6,602
Page 1 of 1